Breast Cancer Drug Approved for Prostates
From Times Staff and Wire Reports
A drug women have long used to battle breast cancer also can help men with advanced prostate cancer, the Food and Drug Administration ruled Wednesday. The drug Taxotere used with the steroid prednisone it has become the first treatment that FDA deems potentially life-lengthening for men whose advanced prostate cancer doesn’t respond to hormone therapy.
In a study comparing the Taxotere and prednisone combination to standard therapy, the Taxotere users lived on average 10 weeks longer.
